Description

Phosphatidylethanolamine (PE) autoantibodies are a type of anti-phospholipid antibody. High levels of anti-phospholipid antibodies are found in patients with autoimmune disorders [i.e., Systemic Lupus Erythematosus (SLE)] and non-autoimmune diseases. Patients with these antibodies may have anti-phospholipid syndrome. Anti-phospholipid antibodies are associated with increased risk for recurrent thrombotic events, thrombocytopenia, endocarditis, stroke, heart attack, autoimmune hemolytic anemia, and fetal loss. Antibodies to superficial cellular phospholipids [i.e., antiphosphatidylserine (aPS) and antiphosphatidylethanolamine (aPE)] are common, and when present alone are not likely to be associated with systemic disease, but may still be associated with fertility defects affecting implantation and early pregnancy. The IgM isotype is rarely associated with thrombosis, but is more commonly found in patients with infectious diseases, neurological conditions (i.e., MS), or autoimmune polyneuropathy. Information from ARUP Laboratories, Specialty Laboratories and Women's Health Primary Care 2002;5(5)314-318. 2007 10 04. Source: Regenstrief Institute

Basic Part Properties

Part Name
Phosphatidylethanolamine Ab
Part Display Name
Phosphatidylethanolamine Ab
Part Type
Component (Describes the core component or analyte measured)
Created On
2006-05-09

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP39368-3

Language Variants Get Info

TagLanguageTranslation
zh-CNChinese (China)磷脂酰乙醇胺抗体
Synonyms: 磷脂酰乙醇胺 Ab
fr-FRFrench (France)Phosphatidyléthanolamine anticorps
pl-PLPolish (Poland)Fosfatydyloetanoloamina Ab
Synonyms: Przeciwciała do fosfatydyloetanoloaminy